Related Experiment Video
Updated: Jun 27, 2026

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions
Published on: July 27, 2017
Structures of the PI3Kα/KRas complex on lipid bilayers reveal molecular mechanisms of PI3Kα activation
Hayarpi Torosyan1, Michael D Paul1, Brigitte G Meyer2
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94158, USA.
Abstract:
PI3Kα is a potent oncogene that converts PIP2 to PIP3 at the plasma membrane upon activation by receptor tyrosine kinases and Ras. To understand the molecular mechanism of PI3Kα activation, we used cryo-electron microscopy to visualize the conformational states that underlie its transition to an active signaling complex. Here, we present structures of the PI3Kα/KRas complex embedded in lipid nanodiscs, revealing a rich ensemble of PI3Kα conformations that capture the progressive release of key inhibitory domains from the PI3Kα catalytic core. PIP2 triggers significant restructuring of active site regulatory motifs while an activating phosphopeptide induces dimerization of the PI3Kα/KRas complex through a p110α catalytic subunit-mediated interface that is sterically occluded in autoinhibited PI3Kα. In cells, dimeric PI3Kα amplifies Akt signaling in response to growth factor stimulation. Collectively, these structures map the conformational landscape of PI3Kα activation and reveal previously unexplored interfaces for potential therapeutic targeting.
Insights
This study reveals the molecular mechanism of PI3Kα activation using cryo-electron microscopy. The findings uncover new therapeutic targets for PI3Kα-driven cancers by mapping its conformational changes.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Phosphoinositide 3-kinase alpha (PI3Kα) is a key oncogene.
- It converts PIP2 to PIP3 at the plasma membrane, crucial for cell signaling.
- Dysregulation of PI3Kα is implicated in various cancers.
Purpose of the Study:
- To elucidate the molecular mechanisms governing PI3Kα activation.
- To visualize the conformational states of PI3Kα during its transition to an active signaling complex.
- To identify potential therapeutic targets for PI3Kα-driven oncogenesis.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was employed to determine high-resolution structures.
- PI3Kα/KRas complexes were reconstituted and studied within lipid nanodiscs.
- Cellular assays were performed to validate findings in a biological context.
Main Results:
- Structures revealed a spectrum of PI3Kα conformations, illustrating the release of inhibitory domains.
- PIP2 binding induced significant restructuring of active site regulatory elements.
- An activating phosphopeptide promoted PI3Kα/KRas complex dimerization via a novel interface.
- Dimeric PI3Kα was shown to amplify Akt signaling in response to growth factors in cells.
Conclusions:
- The study provides a comprehensive map of PI3Kα conformational dynamics during activation.
- Novel interfaces involved in PI3Kα activation and dimerization were identified.
- These findings offer new avenues for developing targeted therapies against PI3Kα-.
More Related Videos
10:31A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
Published on: September 26, 2025
07:26Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes
Published on: October 15, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Second Messengers
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...